Search results for: Health Policy and Regulation
Filter search results
Funding Challenges in the Malaysian Health Care System
7 January 2020
Adrian Towse presented at the Monash Malaysia Health Economics Forum 2019 on three related topics: health system financing in Malaysia; pharmaceutical price regulation and competition in Malaysia; and the potential…
Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation
21 February 2020
…a transition from external health assistance, and donors unlikely to expand or even maintain existing push initiatives, this suggests a grim outlook for future global health innovation and uptake. Recent CGD analysis suggests that governments are…
Mental Health Economics and Policy in a Global Context
1 December 2003
…health policy in low and middle income countries. Health economists have a growing voice in health policy development. But just as it is only recently that mental health policy specifically…
R&D for new drugs to tackle AMR is a high-return investment for all EU member states
19 July 2024
…co-authored by OHE’s Adrian Towse, and the ARMoR model utilised input from OHE’s Grace Hampson, and is based on work by Adrian Towse and Rachel Silverman-Bonnifield. Anderson et al. propose…
Innovation for Health System Efficiency and Improvement
20 November 2023
…(e.g. technology barriers) 2) the health system’s ability to fund or integrate the innovation, and 3) the clinicians’ and patients’ readiness and willingness to engage with the innovation. Overcoming barriers…
Spotlight on OHE: Innovation, Regulation and Antibiotics
30 September 2014
…research and analyses on innovation and antibiotics are available by clicking here. Understanding the connection between regulation and innovation The Regulatory Policy Institute, based in Oxford, holds an annual conference…
OHE Lunchtime Seminar on 23 February 2015: The Impact of Price-cap Regulations on Entry and Exit by Generic Pharmaceutical Firms in Canada
22 January 2015
…Population and Public Health, University of British Columbia, the Director of Vancouver’s Centre for Health Evaluation and Outcome Sciences, and National Director of the CIHR Canadian HIV Trials Network. …
OHE Lunchtime Seminar: Price Regulation of Generics and Drug Shortages
8 November 2018
…health economists who has conducted numerous studies assessing the impact of various types of regulatory instruments and policies on the pharmaceutical marketplace in Canada. This includes price-cap regulations on brand-name…
OHE Lunchtime Seminar: Price Regulation of Generics and Drug Shortages
21 November 2018
…Dr. Aslam Anis is a Professor in the School of Population and Public Health of the University of British Columbia. He is also the Director of the Centre for Health Evaluation and Outcome…